Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 13 of 29
-
Indian Patent Office: Merck’s patent application for HIV drug, raltegravir, is “refused”
A patent that Merck has been pursuing in India since 2007 has been refused by the Indian Patent Office. The...
-
Petro: Providing the protection he didn’t have
When Petro was a teenager selling sex, HIV treatment didn’t exist, at least not as far as he was aware,...
-
Russian patient organizations ask Gilead to disclaim patents for Truvada
On 3 September 2020, 25 patient organizations working within the HIV response in Russia published an open letter to Gilead...
-
Breakthrough success as reformed patent law enters into force in Ukraine
Ukraine’s reformed patent law provides a framework to prevent unlawful patents and monopolies on essential drugs, which have restricted access...
-
Report: 10 years of community-monitoring of ARV procurement in Russia
ITPCru has released its latest report, providing a yearly analysis of community-monitoring of ARV procurement. The 2019 report marks 10...
-
USA-Kenya Trade Agreement: No IP barriers to affordable medicines
“Access to medicines is a fundamental element of the right to health” states our partner, the Kenya Legal and Ethical...
-
CPTPP: Global civil society writes to Thai Prime Minister warning access to treatment is at risk
Civil society groups and non-government organizations in Thailand have, since March 2020, been expressing their grave concerns over the adverse...
-
CSO Open Letter to Thailand’s Prime Minister
CSO Open Letter to Thailand’s Prime Minister and the Chairperson of the Special Committee on the Study of the CPTPP’s...
-
Belarus: Civil society pushes for compulsory license as dolutegravir remains overpriced
Positive Movement (PMPlus) in Belarus, one of our partner organizations, is an NGO representing people living with HIV, advocating for...
-
New money for old drugs: COVID-19 is not a profit-making opportunity
To try to limit the catastrophic impact of COVID-19, a huge amount of funding has been invested into scientific development...
-
Thai civil society opposes patent on an influenza drug, now used for COVID-19
Favipiravir, originally approved as an influenza drug, is being used to treat COVID-19 patients with pneumonia, alongside anti-malarial and anti-retroviral...
-
Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
This week, civil society in Morocco has called for the urgent removal of unnecessary legal barriers, which are “tailor-made for...